- Conference Report
232 Views
18 Pages
Mattias Collin 1, Berit Olofsson 1, Andreas Naegeli 2 and Pontus Nordenfelt 1 [...]
- 34 daysTime to First Decision
Medical Sciences Forum, Volume 40, Issue 1
IOCAB 2025 2025 - 3 articles
The 1st International Online Conference by Antibodies
Online | 13–14 October 2025
Volume Editor:
Arne Skerra, Technical University of Munich, Freising, Germany
Cover Story: The 1st International Online Conference by Antibodies—Therapeutic Antibodies: New Trends in Discovery, Developability and Characterization—was held online on 13 and 14 October 2025. Antibodies represent the most versatile and therapeutically effective biological drugs, accounting for over half of the world's top-selling pharmaceuticals. Addressing remaining questions in drug discovery, together with the emergence of new modalities such as multispecific formats, made this inaugural conference highly relevant. Its primary aim was to provide a robust platform for researchers to showcase and exchange cutting-edge developments and state-of-the-art advances in antibody innovation. Key topics included antibody discovery and engineering; antibody-based therapeutics; immuno-oncology and tumor imaging; humoral immunity; and computational antibody engineering.
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles (3)
- Proceeding Paper
498 Views
10 Pages
Antibody–Drug Conjugates (ADCs) and Their Journey to Autoimmune Disease Immunotherapy
- Angel Justiz-Vaillant
Antibody–drug conjugates (ADCs) represent a novel and rapidly evolving class of targeted therapeutics that combine the high specificity of monoclonal antibodies (mAbs) with the potent cytotoxic effects of small-molecule drugs. These engineered...
- Proceeding Paper
233 Views
8 Pages
Targeting the Tumor Microenvironment with Radiolabeled Antibodies: Bridging Immunotherapy and Molecular Imaging
- Krishnaveni Manubolu and
- Raveesha Peeriga
Radiolabeled monoclonal antibodies represent a promising approach to integrate molecular imaging with immunotherapy for cancer diagnosis and treatment. These antibodies target immune checkpoints and tumor-associated antigens, enabling non-invasive vi...
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Med. Sci. Forum - ISSN 2673-9992